Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Discriminating Borderline From Stage I Invasive Ovarian Cancer (BIOC): a Prospective Multicenter Diagnostic Biomarker Study

NCT06709872 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT06709872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06709872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Discriminating Borderline From Stage I Invasive Ovarian Cancer (BIOC): a Prospective Multicenter Diagnostic Biomarker Study
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Recruiting
Start date
June 3, 2025
Completion date
September 3, 2029
Enrollment
400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

borderline ovarian tumors, stage i ovarian cancer